Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2017
Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in MiceElizabeth Ahern, Heidi Harjunpää, Deborah Barkauskas, et al.
Trials|December 21, 2019
Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)Elizabeth Ahern, Annette Cubitt, Emma Ballard, et al.
Asia-Pacific Journal of Clinical Oncology|April 9, 2026
Clinical Outcomes of the POPCORN Study: Pharmacodynamics of Pre-Operative PD1 CheckpOint Blockade and Receptor Activator of NF-κB Ligand (RANKL) Inhibition in Non-Small Cell Lung Cancer (NSCLC)-A Phase 1B/2 TrialElizabeth Ahern, Cassie Turner, Rishendran Naidoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2024
Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket StudyLoren Michel, Antonio Jimeno, Ammar Sukari, et al.
BMC Infectious Diseases|January 21, 2022
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)Amy Body, Elizabeth Ahern, Luxi Lal, et al.
Cancers|October 26, 2024
Evolving Practice and Outcomes in Grade 2 Glioma: Real-World Data from a Multi-Institutional RegistryLucy Gately, Katharine Drummond, Anthony Dowling, et al.
BMC Cancer|June 2, 2022
Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)Lucy Gately, Katharine Drummond, Mark Rosenthal, et al.
JCO Clinical Cancer Informatics|June 26, 2024
Improving Clinical Registry Data Quality via Linkage With Survival Data From State-Based Population RegistriesSamuel Smith, Kate Drummond, Anthony Dowling, et al.
Oncoimmunology|June 15, 2018
Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasisHeidi Harjunpää, Stephen J Blake, Elizabeth Ahern, et al.
Cancer Research|June 28, 2017
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and MetastasisArabella Young, Shin Foong Ngiow, Jason Madore, et al.
Pageof 4